Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector
Patent
1995-03-29
1998-09-08
Minnifield, Nita
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
4241461, 424 946, 514 2, 514825, 435194, 436506, 436507, 436508, 436509, 536 11, A61K 3900, A61K 39395, A61K 3800, G01N 33564
Patent
active
058041885
ABSTRACT:
A method and composition are provided for treatment of disorders involving immunological dysfunction. The invention comprises the administration of a low level of ribonucleotide polymerase protein or a derivative thereof to a human or animal with an immune dysfunction disorder.
REFERENCES:
patent: 4294818 (1981-10-01), McMichael et al.
patent: 5077211 (1991-12-01), Yarosh
patent: 5116615 (1992-05-01), Gokcen et al.
Kotzin, B.L. et al., "Preferential T-cell Receptor .beta.-chain Variable Gene Use in Myelin Basic Protein-reactive T-cell Clones from Patients with Multiple Sclerosis," PNAS, vol. 88, pp. 9161-9165 (Oct. 1991).
McNeilage, L.J. et al., "Review: Autoantibodies Reactive with Small Ribonucleoprotein Antigens: A Convergence of Molecular Biology Clinical Immunology," J. Clin. Lab. Immunol., vol. 15, pp. 1-17, (1984).
Stetler et al., "Antibodies to Distinct Polypeptides of RNA Polymerase I in Sera From Patients with Rheumatic Autoimmune Disease," PNAS, vol. 79, pp. 7499-7503 (Dec. 1982).
Stetler et al., "Immunization of Rabbits with Purified RNA Polymerase I Induces A Distinct Population of Antibodies Against Nucleic Acids As Well As Anti-RNA Polymerase I Antibodies Both Characteristic of Systematic Lupus Erythematosus," PNAS, vol. 82, pp. 6797-6801 (Oct. 1985).
Reimer et al., "Autoantibody to RNA Polymerase I in Scleroderma Sera," J. Clin. Invest., vol. 79, pp. 65-72 (Jan. 1987).
Biochemical and Organic Compounds for Research and Diagnostic Clinical Reagents Catalog, Sigma Chemical Co., p. 1266 (1988).
Minnifield Nita
Molecular Rx, Inc.
LandOfFree
Method and composition for treatment of disorders involving immu does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method and composition for treatment of disorders involving immu, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method and composition for treatment of disorders involving immu will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1279603